慢性心力衰竭利尿剂抵抗的中西医治疗研究进展
|
摘要
分析慢性心力衰竭治疗中利尿剂抵抗的发生机制,一般认为其与肾功能不全、肾小管细胞肥大、药物之间的相互作用及利尿后钠潴留等有关。现对慢性心力衰竭病人利尿剂抵抗中西医治疗中生活方式干预、利尿剂的管理策略、利尿剂联合其他药物、超滤、中医药治疗等几方面做一综述。
引文
[1] GUPTA S,lNEYSES L.Diuretic usage in heart failure:a continuing conundrum in 2005[J].Eur Heart J,2005,26(7):644-649.
[2] KRAMER B K,SCHWEDA F,RIEGGER G A.Diuretic treatment and diuretic resistance in heart failure [J].Am J Med,1999,106(1):90-96.
[3] HOORN E J,lELLISON D H.Diuretic resistance[J].American Journal of Kidney Diseases,2017,69(1):136-142.
[4] NEUBERG G W,MILLER A B,O′CONNOR C M,et al.Diuretic resistance predicts mortality in patients with advanced heart failure[J].Am Heart J,2002,144(1):31-38.
[5] MARTINS J,LOUREN?O P,ARAùJO J P,et al.Prognostic implications of diuretic dose in chronic heart failure[J].Journal of Cardiovascular Pharmacology and Therapeutics,2011,16(2):185-191.
[6] 李东宝.持续静滴呋塞米在心力衰竭中的应用[J].中华老年多器官疾病杂志,2005,4(4):306-309.
[7] PALAZZUOLI A,PELLEGRINI M,RUOCCO G,et al.Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure:a prospective randomized trial[J].Crit Care,2014,18(3):R134.
[8] JENTZER J C,DEWALD T A,HERNANDEZ A F.Combination of loop diuretics with thiazide-type diuretics in heart failure[J].American College of Cardiology,2010,56(19):1527-1534.
[9] TUTTOLOMONDO A,lPINTO A,DI RAIMONDO D,et al.Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure,after treatment with high dose of furosemide plus hypertonic saline solution(HSS) and after a saline loading[J].Nutr Metab Cardiovasc Dis,2011,21(5):372-379.
[10] MILLER W L,BORGESON D D,GRANTHAM J A,et al.Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure[J].Eur J Heart Fail,2015,17(2):144-150.
[11] DE VECCHIS R,ESPOSITO C,ARIANO C,et al.Hypertonic saline plus i.v.furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure:a meta-analysis of the literature[J].Herz,2014,39(1):1-15.
[12] LIU C,LIU G,ZHOU C X,et al.Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance[J].Canadian Journal of Cardiology,2007,23(11):865-868.
[13] 汪凛,陈礼学,夏旭辉,等.重组人脑利钠肽改善慢性心力衰竭利尿剂抵抗的作用及机制研究[J].疑难病杂志,2015,14(12):1211-1214.
[14] TOVENA D M,PEDRINAZZI C,OGLIARI V,et al.Non-pharmacological therapy of decompensated heart failure:the extracorporeal ultrafiltration[J].Giornale Italianodi Cardiologia,2008,9(10 Suppl 1):118s-122s.
[15] TEO L Y,LIM C P,NEO C L,et al.Ultrafiltration in patients with decompensated heart failure and diuretic resistance:an Asian centre′s experience[J].Singapore Medical Journal,2016,57(7):378-383.
[16] 谭春江,陈文列,林久茂,等.心水通胶囊对慢性心力衰竭患者利尿剂抵抗的临床研究[J].中华中医药学刊,2011,29(4):837-839.
[17] 韦倩,肖雪.于凯成教授应用益气强心利水方治疗心衰利尿剂抵抗患者验案3例[J].中医临床研究,2015,7(22):10-11.
[18] 王俊琴.中西医结合治疗利尿剂抵抗21例[J].中国中医药现代远程教育,2016,14(5):92-94.
[19] 陈少军,张宁,孙久林,等.泻肺利水法治疗慢性心力衰竭伴利尿剂抵抗的临床研究[J].北京中医药,2016,35(7):653-655.
[2] KRAMER B K,SCHWEDA F,RIEGGER G A.Diuretic treatment and diuretic resistance in heart failure [J].Am J Med,1999,106(1):90-96.
[3] HOORN E J,lELLISON D H.Diuretic resistance[J].American Journal of Kidney Diseases,2017,69(1):136-142.
[4] NEUBERG G W,MILLER A B,O′CONNOR C M,et al.Diuretic resistance predicts mortality in patients with advanced heart failure[J].Am Heart J,2002,144(1):31-38.
[5] MARTINS J,LOUREN?O P,ARAùJO J P,et al.Prognostic implications of diuretic dose in chronic heart failure[J].Journal of Cardiovascular Pharmacology and Therapeutics,2011,16(2):185-191.
[6] 李东宝.持续静滴呋塞米在心力衰竭中的应用[J].中华老年多器官疾病杂志,2005,4(4):306-309.
[7] PALAZZUOLI A,PELLEGRINI M,RUOCCO G,et al.Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure:a prospective randomized trial[J].Crit Care,2014,18(3):R134.
[8] JENTZER J C,DEWALD T A,HERNANDEZ A F.Combination of loop diuretics with thiazide-type diuretics in heart failure[J].American College of Cardiology,2010,56(19):1527-1534.
[9] TUTTOLOMONDO A,lPINTO A,DI RAIMONDO D,et al.Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure,after treatment with high dose of furosemide plus hypertonic saline solution(HSS) and after a saline loading[J].Nutr Metab Cardiovasc Dis,2011,21(5):372-379.
[10] MILLER W L,BORGESON D D,GRANTHAM J A,et al.Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure[J].Eur J Heart Fail,2015,17(2):144-150.
[11] DE VECCHIS R,ESPOSITO C,ARIANO C,et al.Hypertonic saline plus i.v.furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure:a meta-analysis of the literature[J].Herz,2014,39(1):1-15.
[12] LIU C,LIU G,ZHOU C X,et al.Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance[J].Canadian Journal of Cardiology,2007,23(11):865-868.
[13] 汪凛,陈礼学,夏旭辉,等.重组人脑利钠肽改善慢性心力衰竭利尿剂抵抗的作用及机制研究[J].疑难病杂志,2015,14(12):1211-1214.
[14] TOVENA D M,PEDRINAZZI C,OGLIARI V,et al.Non-pharmacological therapy of decompensated heart failure:the extracorporeal ultrafiltration[J].Giornale Italianodi Cardiologia,2008,9(10 Suppl 1):118s-122s.
[15] TEO L Y,LIM C P,NEO C L,et al.Ultrafiltration in patients with decompensated heart failure and diuretic resistance:an Asian centre′s experience[J].Singapore Medical Journal,2016,57(7):378-383.
[16] 谭春江,陈文列,林久茂,等.心水通胶囊对慢性心力衰竭患者利尿剂抵抗的临床研究[J].中华中医药学刊,2011,29(4):837-839.
[17] 韦倩,肖雪.于凯成教授应用益气强心利水方治疗心衰利尿剂抵抗患者验案3例[J].中医临床研究,2015,7(22):10-11.
[18] 王俊琴.中西医结合治疗利尿剂抵抗21例[J].中国中医药现代远程教育,2016,14(5):92-94.
[19] 陈少军,张宁,孙久林,等.泻肺利水法治疗慢性心力衰竭伴利尿剂抵抗的临床研究[J].北京中医药,2016,35(7):653-655.